Voyager Therapeutics, Inc. Shareholders' Equity
Voyager Therapeutics, Inc. (VYGR) had Shareholders' Equity of $154.38 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $154.38M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $173.67M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $196.08M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $219.82M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $154.38M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $173.67M 10-Q · filed 2026-08-06 | |
| 2025-12-31 | $196.08M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $219.82M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $243.94M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $272.70M 10-Q · filed 2026-08-06 | |
| 2024-12-31 | $299.76M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $330.31M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $335.42M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $340.89M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $236.32M 10-K · filed 2026-03-09 | |
| 2023-09-30 | $176.22M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $199.03M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $216.96M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $59.02M 10-K · filed 2026-03-09 | |
| 2022-09-30 | $79.82M 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $60.05M 10-Q · filed 2023-11-06 | $60.05M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $75.93M 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $95.06M 10-K · filed 2025-03-11 | |
| 2021-09-30 | $87.42M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $110.54M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $136.21M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $154.32M 10-K · filed 2024-02-28 | |
| 2020-09-30 | $166.24M 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $76.88M 10-Q · filed 2021-11-02 | |
| 2020-03-31 | $79.76M 10-Q · filed 2021-11-02 | |
| 2019-12-31 | $99.51M 10-K · filed 2023-03-07 | |
| 2019-09-30 | $108.16M 10-Q · filed 2020-11-09 | |
| 2019-06-30 | $118.40M 10-Q · filed 2020-11-09 | |
| 2019-03-31 | $100.69M 10-Q · filed 2020-11-09 | |
| 2018-12-31 | $46.45M 10-K · filed 2022-03-08 | |
| 2018-09-30 | $65.59M 10-Q · filed 2019-11-06 | $65.59M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $81.97M 10-Q · filed 2019-11-06 | $81.97M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $98.29M 10-Q · filed 2019-11-06 | |
| 2017-12-31 | $134.05M 10-K · filed 2021-02-25 | |
| 2017-09-30 | $85.21M 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $105.29M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $122.70M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $135.92M 10-K · filed 2020-03-03 | |
| 2016-09-30 | $149.12M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $155.70M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $163.60M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $169.07M 10-K · filed 2019-02-26 | |
| 2015-09-30 | -$47.14M 10-Q · filed 2015-12-17 | |
| 2014-12-31 | -$20.83M 10-K · filed 2018-03-14 | |
| 2013-12-31 | -$3.83M 10-K · filed 2017-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |